Gland Pharma Merger & Restructuring Worth ₹4.81 Cr

Gland Pharma Annual General Meeting

Gland Pharma's shareholders approved the appointment of Xingli Wang as Non-Executive Non-Independent Director via postal ballot. The ordinary resolution passed with 97.07% of votes in favour.

Gland Pharma Investor Presentation: Key Takeaways

Q2 FY27 revenue ₹18,336 Mn (+23% YoY), PAT ₹2,908 Mn (+58%), adj. EBITDA margin 27%. US CDMO and launches lead; India and RoW weak.

Gland Pharma Results Update

Gland Pharma reported Q2FY27 revenue of Rs. 18,336 Mn, up 23% YoY, and PAT of Rs. 2,908 Mn, up 58% YoY. The press release accompanies its quarterly financial results filing.

Gland Pharma Q2 FY27 Results: Net Profit ₹290.8 Cr, Up 58.3% YoY

Gland Pharma Ltd reported revenue from operations of ₹1,834 Cr (+23.3% YoY) and net profit of ₹290.8 Cr (+58.3% YoY) for Q2 FY27.

Key figure

Net profit ₹290.8 Cr · +58.3% YoY

Gland Pharma Regulatory Approval

Gland Pharma received USFDA approval for Methylprednisolone Acetate Injectable Suspension USP in multiple vial formats. The product is bioequivalent to Pfizer's Depo-Medrol in a ~$214M US market.

Gland Pharma Management Change

Gland Pharma appointed Ajay Sahni as CEO of its wholly-owned subsidiary Gland Pharma International Pte. Ltd, effective 2 November 2026. He will lead the Cenexi business.

Dabur India Merger & Restructuring

Dabur India disclosed that Atlanta Body and Health Products, a step-down subsidiary, was liquidated and closed effective 10 November 2026. No consideration or financial amount is stated.

Bondada Engineering Merger & Restructuring Worth ₹0.05 Cr

Bondada Engineering incorporated Bondada International FZ-LLC in RAKEZ, UAE, as a wholly owned subsidiary. The subscription amounts to AED 20,000, about Rs.0.05 Crore.

Value

₹0.05 Cr

Deepak Fertilisers & Petrochemicals Corporation Merger & Restructuring Worth ₹0.75 Cr

Deepak Fertilisers incorporated Mahadhan Nutritek Solutions as a step-down wholly owned subsidiary on 26 October 2026. Initial subscription of Rs 0.75 Crore; no business commenced yet.

Value

₹0.75 Cr

Trident Techlabs Merger & Restructuring Worth ₹1.24 Cr

Trident Techlabs incorporated a 99%-owned UAE subsidiary, Techlabs Engineering Consultancy L.L.C., in Abu Dhabi. The company subscribed AED 4.95 lakh, about Rs.1.24 Crore, for 495 shares.

Value

₹1.24 Cr

Olectra Greentech Merger & Restructuring Worth ₹0 Cr

Olectra Greentech agreed to sell its 34% stake in Evey Trans (UJJ) to related party Evey Trans Private Limited for Rs 34,000. Completion is expected by February 2027.

Value

₹0.00 Cr

Execution

Completion expected by 2027-02-09

Jubilant Ingrevia Merger & Restructuring

Jubilant Ingrevia updated on a restructuring share subscription and purchase agreement closing in two tranches. First tranche is due by November 2026, second by September 2027.

Execution

First tranche by November 2026; second tranche by September 2027